GlassScriptPhysician profile
Alexis Anderson
NPI 1518738061
$1,566.60
in general payments reported to CMS, 2019-2025
24 companies · $988 in 2025
The $988 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $578 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,566.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $323.29 | 2024-2025 | |
| Edwards Lifesciences Corporation | $302.31 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.94 | 2025 | Lifevest |
| Angiodynamics, INC. | $98.85 | 2025 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $74.30 | 2025 | Triclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Lilly USA, LLC | $62.39 | 2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $60.96 | 2024-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $55.12 | 2024-2025 | Onpattro |
| Novo Nordisk INC | $47.09 | 2024-2025 | Rybelsus, Ozempic |
| Kestra Medical Technology Services, INC. | $44.19 | 2025 | Assure Wcd |
| Atricure, INC. | $37.94 | 2025 | Synergy Ablation System |
| Scpharmaceuticals INC. | $35.65 | 2025 | |
| Pfizer INC. | $35.61 | 2025 | |
| Esperion Therapeutics, INC. | $32.57 | 2024-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $29.65 | 2025 | Lokelma |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $25.10 | 2024 | Arcalyst |
| Amgen INC. | $23.91 | 2024 | Repatha |
| Inspire Medical Systems, INC. | $22.67 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $21.75 | 2025 | |
| Boston Scientific Corporation | $21.61 | 2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $21.42 | 2025 | Camzyos |
| Abiomed | $19.21 | 2025 | |
| Cardiac Dimensions, INC. | $15.95 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.